(Q33746351)

29 July 2017

1 reference

title

Mechanisms of drug resistance in chemotherapy for urogenital carcinoma (English)

1 reference

29 July 2017

1 reference

Naito S

1

1 reference

29 July 2017

Yokomizo A

series ordinal

2

1 reference

29 July 2017

Koga H

series ordinal

3

1 reference

29 July 2017

publication date

1 September 1999

1 reference

International Journal of Urology

29 July 2017

published in

1 reference

29 July 2017

volume

6

1 reference

29 July 2017

issue

9

1 reference

29 July 2017

page(s)

427-439

1 reference

Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

Do cMOAT (MRP2), other MRP homologues, and LRP play a role in MDR?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

Hepatocellular transport: role of ATP-binding cassette proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

The physiological function of drug-transporting P-glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

Function, evolution and structure of multidrug resistance protein (MRP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

Mutations in the canilicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

Isolation of a novel human canalicular multispecific organic anion transporter, cMOAT2/MRP3, and its expression in cisplatin-resistant cancer cells with decreased ATP-dependent drug transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

The drug resistance-related protein LRP is the human major vault protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

Drug resistance to cis-diamminedichloroplatinum (II) in Chinese hamster ovary cell lines transfected with glutathione S-transferase pi gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

Gamma-glutamylcysteine synthetase gene overexpression results in increased activity of the ATP-dependent glutathione S-conjugate export pump and cisplatin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): protective effect of human thioredoxin against CDDP-induced cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

Structure and mechanism of DNA topoisomerase II

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

Topoisomerase inhibitors. A review of their therapeutic potential in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

Isolation of cDNA clones encoding the beta isozyme of human DNA topoisomerase II and localisation of the gene to chromosome 3p24

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

DNA topoisomerase I and II as targets for rational design of new anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

The role of an inverted CCAAT element in transcriptional activation of the human DNA topoisomerase IIalpha gene by heat shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

MDR1 RNA levels in human renal cell carcinomas: correlation with grade and prediction of reversal of doxorubicin resistance by quinidine in tumor explants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

Phase I/II trial of dexverapamil plus vinblastine for patients with advanced renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

A phase II study of vinblastine in combination with acrivastine in patients with advanced renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

Non-P-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

Increased expression of T-plastin gene in cisplatin-resistant human cancer cells: identification by mRNA differential display

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

Immunohistochemical detection of P-glycoprotein and GSTP1-1 in testis cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

Sensitivity of testis tumour cells to chemotherapeutic drugs: role of detoxifying pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

Adenocarcinoma of the prostate: innovations in management

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

Management of hormone refractory prostate cancer: current standards and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

P-glycoprotein binding and modulation of the multidrug-resistant phenotype by estramustine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1442-2042.1999.00088.X

10.1046/J.1442-2042.1999.00088.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference